Withdrawal of Catena®: a Letter to Health Canada
Following the decision of Health Canada to withdraw the drug Catena® (idebenone) in Canada, CAFA has prepared two documents to communicate to Health Canada the reaction of people with Friedreich’s ataxia to this decision and its support of the demand to make Catena® (Idebenone) available through a special access program....